# Aclaris Therapeutics, Inc. (ACRS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ACRS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.63M | $ -41.33M | $ -38.07M | $ 0 | $ 124.58M |
| 2025 | $ 8.01M | $ -66.48M | $ -49.21M | $ 2.12M | $ 103.08M |
| 2024 | $ 19.68M | $ -138.81M | $ -58.87M | $ 0 | $ 155.55M |
| 2023 | $ 33.79M | $ -95.67M | $ -86.10M | $ 426.0K | $ 157.18M |
| 2022 | $ 33.24M | $ -97.09M | $ -76.16M | $ 684.0K | $ 197.62M |
| 2021 | $ 8.04M | $ -108.01M | $ -62.34M | $ 693.0K | $ 197.34M |
| 2020 | $ 8.26M | $ -64.99M | $ -49.79M | $ 11.26M | $ 37.65M |
| 2019 | $ 16.76M | $ -208.27M | $ -126.57M | $ 637.0K | $ 69.91M |
| 2018 | $ 13.33M | $ -175.31M | $ -134.93M | $ 30.52M | $ 215.12M |
| 2017 | $ 2.27M | $ -92.31M | $ -75.30M | $ 142.0K | $ 225.26M |
| 2016 | $ 0 | $ -66.15M | $ -47.93M | $ 0 | $ 169.49M |
| 2015 | $ 0 | $ -28.87M | $ -29.31M | $ 0 | $ 92.52M |
| 2014 | $ 0 | $ -13.33M | $ -11.38M | $ 0 | $ -20.76M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.44 |
| Current Ratio | 3.46 |

## Other views

- [Metrics](https://sponda.capital/en/ACRS.md)
- [Charts](https://sponda.capital/en/ACRS/charts.md)
- [Compare](https://sponda.capital/en/ACRS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.